Urokinase plasminogen activator and cathepsin D in micrometastatic cells of patients with primary breast cancer

被引：0
|
作者：
Solomayer, EF [1 ]
Diel, IJ [1 ]
Gollan, C [1 ]
Meyberg, G [1 ]
Bode, S [1 ]
Wallwiener, D [1 ]
Bastert, G [1 ]
机构：
[1] Univ Heidelberg, Dept OB GYN, D-69115 Heidelberg, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(97)89259-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P41
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [41] High concentration of urokinase-type plasminogen activator receptor in the serum of women with primary breast cancer
    Thielemann, Anna
    Baszczuk, Aleksandra
    Kopczynski, Przemyslaw
    Kopczynski, Zygmunt
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (05): : 440 - 445
  • [42] UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PLASMA FROM BREAST-CANCER PATIENTS
    BACH, F
    GRONDAHLHANSEN, J
    AGERLIN, N
    MUNKHOLMLARSEN, P
    NIELSEN, LS
    DOMBERNOWSKY, P
    DANO, K
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (09): : 1553 - 1553
  • [43] Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients
    Chung, HC
    Rha, SY
    Park, JO
    Yoo, NC
    Kim, JH
    Roh, JK
    Min, JS
    Lee, KS
    Kim, BS
    Kim, JJ
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 49 (01) : 41 - 50
  • [44] UROKINASE PLASMINOGEN-ACTIVATOR AS A PROGNOSTIC MARKER IN DIFFERENT SUBGROUPS OF PATIENTS WITH BREAST-CANCER
    DUFFY, MJ
    REILLY, D
    MCDERMOTT, E
    OHIGGINS, N
    FENNELLY, JJ
    ANDREASEN, PA
    CANCER, 1994, 74 (08) : 2276 - 2280
  • [45] Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients
    Hyun Cheol Chung
    Sun Young Rha
    Joon Oh Park
    Nae Choon Yoo
    Joo Hang Kim
    Jae Kyung Roh
    Jin Sik Min
    Kyong Sik Lee
    Byung Soo Kim
    Jin Ju Kim
    Breast Cancer Research and Treatment, 1998, 49 : 41 - 50
  • [46] Circulating levels of urokinase-type plasminogen activator (uPA) in breast and pancreatic cancer patients
    Hamer, PJ
    Marx, JH
    Leitzel, K
    Ali, S
    Clarke, L
    Demers, L
    Harvey, HA
    Linnartz, R
    Lipton, A
    Mietlowski, W
    Carney, WP
    CLINICAL CHEMISTRY, 2005, 51 : A53 - A54
  • [47] RELATIONSHIP BETWEEN CATHEPSIN-D, UROKINASE, AND PLASMINOGEN-ACTIVATOR INHIBITORS IN MALIGNANT VS BENIGN BREAST-TUMORS
    FOUCRE, D
    BOUCHET, C
    HACENE, K
    POURREAUSCHNEIDER, N
    GENTILE, A
    MARTIN, PM
    DESPLACES, A
    OGLOBINE, J
    BRITISH JOURNAL OF CANCER, 1991, 64 (05) : 926 - 932
  • [48] Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer
    Riisbro, R
    Christensen, IJ
    Piironen, T
    Greenall, M
    Larsen, B
    Stephens, RW
    Han, C
    Hoyer-Hansen, G
    Smith, K
    Brünner, N
    Harris, AL
    CLINICAL CANCER RESEARCH, 2002, 8 (05) : 1132 - 1141
  • [49] Urokinase-type Plasminogen Activator and Plasminogen-activator-inhibitor Type 1 Predict Metastases in Good Prognosis Breast Cancer Patients
    de Cremoux, Patricia
    Grandin, Laure
    Dieras, Veronique
    Savignoni, Alexia
    Degeorges, Armelle
    Salmon, Remy
    Bollet, Marc A.
    Reyal, Fabien
    Sigal-Zafrani, Brigitte
    Vincent-Salomon, Anne
    Sastre-Garau, Xavier
    Magdelenat, Henri
    Mignot, Laurent
    Fourquet, Alain
    ANTICANCER RESEARCH, 2009, 29 (05) : 1475 - 1482
  • [50] PROGNOSTIC-SIGNIFICANCE OF THE UROKINASE-TYPE PLASMINOGEN ACTIVATORS AND CATHEPSIN-D IN BREAST-CANCER
    JANICKE, F
    SCHMITT, M
    IRMENERNST, E
    GRAEFF, H
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1991, 250 (1-4) : 234 - 237
12345